• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Hematology Reports

    Hematology Reports

    JournalISSN 2038-8322eISSN 2038-8330中科院 医学 4区

    年发文量

    研究主题

    论文(762)

    排序
    1Initially Suspected Acute Promyelocytic Leukemia: A Case-Based Narrative Review of Diagnostic Mimics and Diagnostic Revision
    Anna Ui,Shinichiro Takahashi

    Acute promyelocytic leukemia (APL) is a hematologic emergency in which all-trans retinoic acid (ATRA) should be initiated as soon as the disease is suspected; however, neoplastic and non-neoplastic conditions can closely mimic APL. This case-based narrative review examines findings that prompted suspicion of APL and those that led to diagnostic revision. A broadened literature search and patient-level extraction yielded 41 selected patients from 34 primary reports. Larger overlapping molecular cohorts and mechanistic studies were used for qualitative interpretation without adding their patients to the quantitative denominator. Median age was 48 years (range, 1.25–77), and 20 patients (48.8%) were female. Morphologic findings and an APL-like immunophenotype contributed to suspicion in 39/41 (95.1%) and 30/41 (73.2%), respectively; coagulation abnormalities contributed in 17/41 (41.5%). Negative PML::RARA or RARA-related testing contributed to diagnostic revision in 40/41 (97.6%), and identification of an alternative fusion or mutation contributed in 35/41 (85.4%). RARG rearrangements were identified in 14/41 patients (34.1%). All frequencies are descriptive and depend on reporting and variable-specific assessability. An APL-like phenotype is not equivalent to molecularly defined APL: rapid PML::RARA testing should accompany immediate empiric ATRA, and negative or equivocal results should prompt review of assay coverage and, when appropriate, orthogonal and broader molecular testing.

    2026
    引用
    AI阅读
    加入学术空间
    2Clinicopathological Features of Non-Hodgkin Lymphoma Involving the ENT Region: A Single-Center of 2019–2021 Retrospective Case Series
    Oana Silvana Sarău, Ioana Ionita,Delia Ioana Horhat,Despina Popovici Calamar,Dacian Nicolae Oros, Doina Chioran, Richard Dahma, Marilena Dinuţi, Ana-Cristiane Dragomir, Sergio Liga, Alexandra Barzuca, Mirela Voicu

    Background: Non-Hodgkin lymphoma (NHL) involving the ear, nose, and throat (ENT) region encompasses several established lymphoma entities with heterogeneous anatomical presentations. This study describes the clinicopathological features of a selected institutional cohort. Methods: We conducted a single-center retrospective case series of adult patients with NHL documented in institutional records during 2019–2021. Extranodal ENT-organ involvement was distinguished from cervical nodal disease without documented ENT-organ infiltration. Clinical, pathological, staging, treatment, and available follow-up information were reviewed descriptively. Results: Nineteen distinct patients were included (twelve in 2019, three in 2020, four in 2021). The median recorded age was 64 years, and 10 patients (52.6%) were male. Fourteen patients (73.7%) had extranodal ENT-organ involvement, and five (26.3%) had cervical nodal involvement only. The palatine tonsil was the most frequent index site (42.1%). Follicular lymphoma and mantle cell lymphoma were each recorded in four patients (21.1%). All final pathological diagnoses were recorded as B-cell lymphoma entities, although individual immunophenotypic findings were incomplete. Conclusions: This single-center retrospective case series highlights the anatomical and histopathological heterogeneity of NHL involving ENT-region structures. Larger multicenter studies with standardized clinicopathological assessment and longitudinal follow-up are needed to further characterize these presentations and their clinical outcomes.

    2026
    引用
    AI阅读
    加入学术空间
    3Humoral Immune Reconstitution with the Use of Bruton Tyrosine Kinase Inhibitor Treatment for Patients with Waldenström Macroglobulinemia
    Tanim Jain,Nisha Hariharan,Benjamin Heyman

    Background/Objectives: Waldenström macroglobulinemia (WM) is a B-cell lymphoma, defined by immunoglobulin M monoclonal gammopathy, lymphoplasmacytic marrow infiltration, and impaired humoral immunity with increased infections. With advances in WM treatment, Bruton tyrosine kinase inhibitors (BTKis) are increasingly used as first-line therapy. Studies show that BTKi use in chronic lymphocytic leukemia is associated with partial humoral immune reconstitution and decreased rates of infections. This study investigates whether BTKi treatment for WM is associated with a reduced risk of infectious complications compared with traditional systemic therapies. Methods: In this single-institution retrospective analysis, we compared immunoglobulin levels and infectious complications in WM patients treated with BTKis, rituximab, or chemoimmunotherapy. Results: Treatment of WM with BTKis was associated with an increase in serum IgA levels by 33%. Rituximab monotherapy was also associated with increased IgA (9%), but after 24 months. Patients treated with BTKis developed fewer infections, 50% compared with 68.4–71.4% of patients in other groups. Severe infections (≥grade 3) occurred most frequently in patients treated with chemoimmunotherapy. There was no correlation between development of infections and serum IgG levels or neutrophil count. Conclusions: Results demonstrate that treatment with BTKis is associated with a decreased risk of infection over time due to partial humoral immune reconstitution, as evidenced by increasing serum IgA.

    2026
    引用
    AI阅读
    加入学术空间
    4Aplastic Anaemia-Associated PNH Through Successive Therapeutic Eras: from Persistent Extravascular Haemolysis to Complete Haematological Response
    Irena Preložnik Zupan,Saša Anžej Doma,Katarina Reberšek,Karla Rener

    Background and Clinical Relevance: C5 inhibitors effectively control intravascular haemolysis (IVH) in paroxysmal nocturnal haemoglobinuria (PNH), but persistent extravascular haemolysis (EVH) may result in ongoing anaemia and transfusion dependence. Iptacopan, an oral complement factor B inhibitor, targets both mechanisms of haemolysis. Case Presentation: We report the 26-year clinical course of a female patient who developed PNH following severe aplastic anaemia. Despite long-term treatment with eculizumab and subsequently ravulizumab, she remained transfusion-dependent due to persistent EVH. The clinical course included three pregnancies, with successful delivery during the third following intensified eculizumab treatment and multidisciplinary management. Switching to iptacopan in 2024 resulted in normalization of haemoglobin, reticulocyte counts and lactate dehydrogenase levels, and complete transfusion independence. Conclusions: This case illustrates the evolving clinical and therapeutic challenges of aplastic anaemia-associated PNH over 26 years. It highlights the limitations of long-term C5 inhibition in controlling EVH and the potential of proximal complement inhibition to achieve sustained haematological recovery and transfusion independence.

    2026
    引用
    AI阅读
    加入学术空间
    5Anemia: A Common Problem That Should Not Be Overlooked
    Efthymia Vlachaki,Theodora-Maria Venou

    Anemia is one of the most common health conditions worldwide, affecting people of different ages and backgrounds [...]

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 762 篇论文

    高被引作者

    作者引用发文
    Sergio Siragusa2537
    Marco Santoro2433
    Vincenzo Accurso2382
    Salvatrice Mancuso2222
    Mariasanta Napolitano2222
    Marta Mattana2171
    Giorgia Vajana2171
    Federica Russello2171
    Giovanni Martinelli14216
    Matthew Yuan-Kun Wei1081

    高产作者

    作者引用发文
    Giovanni Martinelli14216
    Claudio Cerchione9011
    Takashi Sonoki198
    Mushino Toshiki188
    Rattanathammethee Thanawat978
    Mario Petrini688
    Akinori Nishikawa187
    Shogo Murata187
    Shosaku Nomura627
    Ekarat Rattarittamrong977

    相关期刊

    Acta haematologica
    Best Practice & Research Clinical Haematology
    Therapeutic advances in hematology
    Case reports in hematology
    Blood research
    Leukemia research reports
    Journal of hematology
    Turkish Journal of Hematology
    Turkish journal of haematology : official journal of Turkish Society of Haematology
    Hematology/Oncology and Stem Cell Therapy